| Literature DB >> 27209377 |
João Mangussi-Gomes1, Fernando Danelon-Leonhardt2, Guilherme Figner Moussalem1, Nicolas Galat Ahumada1, Cleydson Lucena Oliveira1, Flávio Carneiro Hojaij3.
Abstract
INTRODUCTION: Squamous cell carcinoma of the larynx and hypopharynx has the potential to invade the thyroid gland. Despite this risk, the proposition of either partial or total thyroidectomy as part of the surgical treatment of all such cases remains controversial.Entities:
Keywords: Carcinoma espinocelular; Faringectomia; Hipofaringe; Hypopharynx; Laringe; Laringectomia; Laryngectomy; Larynx; Pharyngectomy; Squamous cell carcinoma; Thyroidectomy; Tireoidectomia
Mesh:
Year: 2016 PMID: 27209377 PMCID: PMC9444747 DOI: 10.1016/j.bjorl.2016.03.019
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Patients with laryngeal and/or hypopharyngeal SCC submitted to TL or TPL with HT or TT – clinical data.
| Variable | |
|---|---|
| T 3 | 26 (31.3%) |
| T 4a | 57 (68.7%) |
| N 0 | 45 (54.2%) |
| N 1 | 10 (12.0%) |
| N 2a | 8 (9.6%) |
| N 2b | 7 (8.4%) |
| N 2c | 11 (13.3%) |
| N 3 | 2 (2.4%) |
| M 0 | 83 (100%) |
| M 1 | 0 (0%) |
| III | 15 (18.1%) |
| IVa | 66 (79.5%) |
| IVb | 2 (2.4%) |
| TL/TPL + HT | 54 (65.1%) |
| TL/TPL + TT | 29 (34.9%) |
SCC, squamous cell carcinoma; TL, total laryngectomy; TPL, total pharyngolaryngectomy; HT, hemithyroidectomy; TT, total thyroidectomy; TL/TPL + HT, total laryngectomy or total pharyngolaryngectomy with hemithyroidectomy; TL/TPL + TT, total laryngectomy or total pharyngolaryngectomy with total thyroidectomy.
TNM and Global tumor staging, according to American Joint Committee on Cancer (AJCC) criteria.
Comparison between groups of patients with laryngeal and/or hypopharyngeal SCC submitted to TL or TPL with HT or TT – clinic-epidemiological data.
| Variable | Thy Pos | Thy Neg | |
|---|---|---|---|
| 1.000 | |||
| Male | 14 (93.3%) | 64 (94.1%) | |
| Female | 1 (6.7%) | 4 (5.9%) | |
| 1.000 | |||
| Yes | 14 (93.3%) | 60 (88.2%) | |
| No | 1 (6.7%) | 8 (11.8%) | |
| 0.728 | |||
| Larynx | 13 (86.7%) | 55 (80.9%) | |
| Hypopharynx | 2 (13.3%) | 13 (19.1%) | |
| 0.129 | |||
| T 3 | 2 (0%) | 24 (35.3%) | |
| T 4a | 13 (100%) | 44 (54.7%) | |
| N 0 | 8 (53.3%) | 37 (54.4%) | 1.000 |
| N 1 | 3 (20.0%) | 7 (10.3%) | 0.377 |
| N 2a | 1 (6.7%) | 7 (10.3%) | 1.000 |
| N 2b | 1 (6.7%) | 6 (8.8%) | 1.000 |
| N 2c | 1 (6.7%) | 10 (14.7%) | 0.679 |
| N 3 | 1 (6.7%) | 1 (1.5%) | 0.331 |
| 1.000 | |||
| M 0 | 15 (100%) | 68 (100%) | |
| M 1 | 0 (0%) | 0 (0%) | |
| III | 1 (6.7%) | 14 (20.6%) | 0.2849 |
| IVa | 13 (86.7%) | 53 (77.9%) | 0.7248 |
| IVb | 1 (6.7%) | 1 (1.5%) | 0.331 |
| 0.136 | |||
| TL/TPL + HT | 7 (46.7%) | 54 (79.4%) | |
| TL/TPL + TT | 8 (53.3%) | 24 (21.6%) | |
SCC, squamous cell carcinoma; TL, total laryngectomy; TPL, total pharyngolaryngectomy; HT, hemithyroidectomy; TT, total thyroidectomy; TL/TPL + HT, total laryngectomy or total pharyngolaryngectomy with hemithyroidectomy; TL/TPL + TT, total laryngectomy or total pharyngolaryngectomy with total thyroidectomy; Thy Pos, thyroid gland positive for malignancy; Thy Neg, thyroid gland negative for malignancy.
TNM and Global tumor staging, according to American Joint Committee on Cancer (AJCC) criteria.
Comparison between groups of patients with laryngeal and/or hypopharyngeal SCC submitted to TL or TPL with HT or TT – age and largest size of the tumor.
| Variable | Thy Pos | Thy Neg | |
|---|---|---|---|
| Mean ± SD | 60.7 ± 11.5 | 59.2 ± 9.9 | 0.678 |
| Mean ± SD | 5.5 ± 2.7 | 4.3 ± 1.5 | 0.943 |
SCC, squamous cell carcinoma; TL, total laryngectomy; TPL, total pharyngolaryngectomy; HT, hemithyroidectomy; TT, total thyroidectomy; Thy Pos, thyroid gland positive for malignancy; Thy Neg, thyroid gland negative for malignancy; SD, standard deviation.
Comparison between groups of patients with laryngeal and/or hypopharyngeal SCC submitted to TL or TPL with HT or TT – anatomopathological data.
| Variable | Thy Pos | Thy Neg | |
|---|---|---|---|
| Pyriform sinus | 2 (13.3%) | 30 (44.1%) | 0.039 |
| Anterior commissure | 13 (86.7%) | 38 (55.9%) | 0.039 |
| Subglottis | 14 (93.3%) | 36 (52.9%) | 0.003 |
| Thyroid cartilage | 12 (80.0%) | 37 (54.4%) | 0.086 |
| Cricoid cartilage | 11 (73.3%) | 10 (14.7%) | <0.001 |
| Well differentiated | 5 (33.3%) | 30 (44.1%) | 0.568 |
| Moderately well differentiated | 7 (46.7%) | 27 (39.7%) | 0.773 |
| Poorly differentiated | 3 (20.0%) | 11 (16.2%) | 0.711 |
| 0.766 | |||
| Yes | 6 (40.0%) | 23 (33.8%) | |
| No | 9 (60.0%) | 45 (66.2%) | |
| 0.474 | |||
| Yes | 4 (26.7%) | 12 (17.6%) | |
| No | 11 (73.3%) | 56 (82.4%) | |
SCC, squamous cell carcinoma; TL, total laryngectomy; TPL, total pharyngolaryngectomy; HT, hemithyroidectomy; TT, total thyroidectomy; Thy Pos, thyroid gland positive for malignancy; Thy Neg, thyroid gland negative for malignancy; SD, standard deviation.
Statistically significant value (p < 0.05).
Association between thyroid gland invasion by SCC and anatomopathological data – odds ratio and 95% confidence interval.
| Variable | Thy Pos | Thy Neg | OR (95% CI) |
|---|---|---|---|
| 5.13 (1.07–24.5) | |||
| Yes | 13 | 38 | |
| No | 2 | 30 | |
| 12.44 (1.55–100.00) | |||
| Yes | 14 | 36 | |
| No | 1 | 32 | |
| 15.95 (4.23–60.11) | |||
| Yes | 11 | 10 | |
| No | 4 | 58 | |
OR, odds ratio; 95% CI, 95% confidence interval.
Statistically significant values (p < 0.05).